CAR-T cell therapy for acute lymphoblastic laeukemia, illustration - stock illustration

Illustration of chimeric antigen receptor (CAR) T cells (blue) attacking acute lymphoblastic leukaemia (ALL) cells (purple). ALL is a rare cancer where excess white blood cell precursors called lymphoblasts form in the bone marrow. It affects children and adults, and is the most common form of leukaemia in children. CAR-T therapy is a type of immunotherapy that genetically modifies a patient's own T cells, a form of white blood cell, to recognise and destroy cancer cells